Review summary
Teaching objective: Provide primary care survivorship care for a premenopausal woman of 45 after mastectomy for stage IA hormone receptor-positive breast cancer: monitor adjuvant tamoxifen (vasomotor symptoms, abnormal bleeding, and clot symptoms), surveil the remaining breast with a yearly mammogram and no routine blood tests or body imaging, counsel on lymphedema risk and bone health, screen for distress, arrange the germline genetic assessment missed at diagnosis, and respect her informed decision not to have reconstruction or wear a prosthesis.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| February 18, 1934 | Born in New York City. | CLM-0001 |
| 1977 | A breast tumor proved benign; talk on silence to the Modern Language Association. | CLM-0003 |
| Labor Day (September 4), 1978 | Found a lump in her right breast at self-examination. | CLM-0004 |
| 1978 | Breast cancer diagnosed; mastectomy; declined a prosthesis. | CLM-0004, CLM-0005 |
| 1980 | Published The Cancer Journals. | CLM-0006 |
| 1984 | Learned that the cancer had spread to her liver; chose alternative treatments rather than more surgery. | CLM-0007 |
| 1988 | Published A Burst of Light. | CLM-0008 |
| 1991 | Named poet laureate of New York State. | CLM-0008 |
| November 17, 1992 | Died on St. Croix. | CLM-0009 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Audre Lorde was born Audrey Geraldine Lorde on February 18, 1934, in New York City; her parents were immigrants from Grenada. | confirmed | Audre Lorde supports Brandman M. Audre Lorde supports Audre Lorde Papers: finding aid, biographical note supports |
| D | Lorde was a poet, essayist, and novelist. In her poetry and prose she wrote about matters important to her as a woman of color, as a lesbian, as a mother, and as a feminist; a reference biography describes her as an African American lesbian feminist and poet. Her identity is recorded as her published work and the cited sources describe it, and only in these terms. |
confirmed | Audre Lorde Papers: finding aid, biographical note supports Lorde, Audre Geraldine. The Scribner Encyclopedia of American Lives supports Audre Lorde supports Brandman M. Audre Lorde supports |
| D | In 1977 a doctor found a tumor in Lorde's breast that, after about three weeks of uncertainty, proved benign. In a talk given that year to the Modern Language Association she said: "Your silence will not protect you." A benign breast tumor in 1977; the organ is not identified further in the fetched source. One biography dates her breast cancer diagnosis to 1977 (see the editorial resolutions). |
confirmed | Popova M. Audre Lorde on the Transformation of Silence into Language and Action supports Brandman M. Audre Lorde context |
| D | On Labor Day 1978, during a routine self-examination, Lorde found a lump in her right breast; a diagnosis of malignancy and a mastectomy followed. She described the experience in The Cancer Journals. The documented diagnosis that anchors the synthetic episode. Tumor type, size, stage, receptor status, and any treatment besides the mastectomy are not given in the fetched sources. |
confirmed | Smith TK. How Audre Lorde's Experience of Breast Cancer Fortified Her Revolutionary Politics (foreword to The Cancer Journals, Penguin Classics edition) supports Audre Lorde Papers: finding aid, biographical note supports |
| D | After her mastectomy Lorde chose never to hide the fact of her missing breast. She refused to wear the "wad of lambswool pressed into a pale pink breast-shaped pad" pushed on her by nurses and medical counselors, and she was repeatedly scolded for posing a threat to cancer patient "morale." Her decision about a prosthesis is recorded as her own considered choice and is respected in the synthetic episode. |
confirmed | Smith TK. How Audre Lorde's Experience of Breast Cancer Fortified Her Revolutionary Politics (foreword to The Cancer Journals, Penguin Classics edition) supports Audre Lorde Papers: finding aid, biographical note supports |
| D | The Cancer Journals (Spinsters, Ink, 1980), her first prose collection, combines journal entries from her hospital stay and recovery with essays; it won the American Library Association Gay Caucus Book of the Year award for 1981. | confirmed | Audre Lorde supports Audre Lorde Papers: finding aid, biographical note supports Brandman M. Audre Lorde supports Smith TK. How Audre Lorde's Experience of Breast Cancer Fortified Her Revolutionary Politics (foreword to The Cancer Journals, Penguin Classics edition) supports |
| D | In 1984, six years after her mastectomy, Lorde learned that her breast cancer had spread to her liver. This time she chose alternative treatments rather than more surgery, and she wrote about it in the title essay of A Burst of Light. Later than the synthetic episode and not used in it; her treatment choice is recorded as her own decision without comment. |
confirmed | Review of A Burst of Light, by Audre Lorde supports Audre Lorde Papers: finding aid, biographical note supports |
| D | A Burst of Light, published by Firebrand in 1988, won a book award from the Before Columbus Foundation. Lorde was the poet laureate of New York State in 1991 and 1992. | confirmed | Audre Lorde supports Brandman M. Audre Lorde supports |
| D | Lorde died on November 17, 1992, at Christiansted on St. Croix in the U.S. Virgin Islands, at 58. Sources give the cause as liver cancer, the spread of her breast cancer. Record the death as a fact without detail. |
confirmed | Audre Lorde Papers: finding aid, biographical note supports Lorde, Audre Geraldine. The Scribner Encyclopedia of American Lives supports Audre Lorde supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1978 breast cancer and mastectomy | active | confirmed | both_with_link | CLM-0004, CLM-0005 |
| S | Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent) | active | confirmed | active | CLM-0004 |
| S | Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesis | active | confirmed | active | CLM-0004, CLM-0005 |
| S | Long-term use of tamoxifen as adjuvant endocrine therapy | active | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-03-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | http://loinc.org · 44261-6 |
| S | 2026-03-09 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | http://loinc.org · 70274-6 |
| S | 2026-06-29 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 2026-06-29 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | http://loinc.org · 70274-6 |
| S | 2026-09-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-10-19 | Cholesterol [Mass/volume] in Serum or Plasma | 182 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-10-19 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 64 mg/dL Reference >=50 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-10-19 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 98 mg/dL Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-10-19 | Triglyceride [Mass/volume] in Serum or Plasma | 100 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-10-19 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2026-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-10-19 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-03-09 | Body height | 168 cm | 8302-2 | S |
| 2026-03-09 | Body weight | 72 kg | 29463-7 | S |
| 2026-03-09 | Body mass index (BMI) [Ratio] | 25.5 kg/m2 | 39156-5 | S |
| 2026-03-09 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-03-09 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-03-09 | Heart rate | 74 /min | 8867-4 | S |
| 2026-03-09 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-09 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-03-30 | Body height | 168 cm | 8302-2 | S |
| 2026-03-30 | Body weight | 72.4 kg | 29463-7 | S |
| 2026-03-30 | Body mass index (BMI) [Ratio] | 25.7 kg/m2 | 39156-5 | S |
| 2026-03-30 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 2026-03-30 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-03-30 | Heart rate | 72 /min | 8867-4 | S |
| 2026-03-30 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-30 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-03-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-06-29 | Body height | 168 cm | 8302-2 | S |
| 2026-06-29 | Body weight | 71.6 kg | 29463-7 | S |
| 2026-06-29 | Body mass index (BMI) [Ratio] | 25.4 kg/m2 | 39156-5 | S |
| 2026-06-29 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-06-29 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-06-29 | Heart rate | 70 /min | 8867-4 | S |
| 2026-06-29 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-06-29 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-09-28 | Body height | 168 cm | 8302-2 | S |
| 2026-09-28 | Body weight | 71.8 kg | 29463-7 | S |
| 2026-09-28 | Body mass index (BMI) [Ratio] | 25.4 kg/m2 | 39156-5 | S |
| 2026-09-28 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-09-28 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-09-28 | Heart rate | 72 /min | 8867-4 | S |
| 2026-09-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-10-19 | Body height | 168 cm | 8302-2 | S |
| 2026-10-19 | Body weight | 71.5 kg | 29463-7 | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 25.3 kg/m2 | 39156-5 | S |
| 2026-10-19 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-10-19 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-10-19 | Heart rate | 70 /min | 8867-4 | S |
| 2026-10-19 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-19 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: poet and essayist; writes most days and gives readings
- S Never smoker; alcohol rarely; walks most days; cooks most meals at home with plenty of vegetables and whole grains
- S Lives with her partner and her two teenage children; independent
- S Supports: her family and a wide circle of writers and friends
Functional status
- S Independent in all activities of daily living; full range of motion of the right shoulder; writing and walking daily
Mental status
- S Alert, articulate, and direct; asks for complete information and makes her own decisions about her care
- S Mood euthymic; PHQ-9 and GAD-7 in the minimal range
Allergies and medications
Allergies
- S No known allergy
Medications
- S Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five years
Procedures and immunizations
Procedures
- S Diagnostic bilateral mammography after a self-detected right breast lump: 1.6 cm irregular mass in the upper outer right breast, BI-RADS 5; left breast normal
- S Right breast and axillary ultrasound: 1.6 cm irregular hypoechoic mass at 10 o'clock; normal axillary lymph nodes
- S Ultrasound-guided core needle biopsy of the right breast mass: invasive ductal carcinoma, grade 2; ER 90 percent, PR 60 percent, HER2 1+ (negative), Ki-67 12 percent
- S Right total mastectomy with flat closure and no reconstruction, her informed choice. Pathology: invasive ductal carcinoma 1.6 cm, grade 2, margins clear, no lymphovascular invasion; pT1c pN0(sn), stage IA. Recurrence score (21-gene assay) 14
- S Right axillary sentinel lymph node biopsy at mastectomy: 0 of 2 nodes involved
- S Diagnostic mammography of the left breast one year after diagnosis: scattered fibroglandular tissue, no suspicious findings, BI-RADS 1
- S Genetic counseling for hereditary breast cancer risk: pedigree taken and multigene panel testing for inherited cancer risk sent; result pending at the end of the episode
- S Cervical sampling for cytology with human papillomavirus co-testing; result pending at the end of the episode
Immunizations
- S 2025-10-14: Influenza vaccine, 2025-2026 season
- S 2019-05-06: Tdap vaccine
- S 2026-10-19: Influenza vaccine, 2026-2027 season
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1977: Breast tumor found by a doctor, benign after about three weeks of uncertainty (CLM-0003)
- D 1978: Lump in the right breast found at self-examination on Labor Day, followed by a diagnosis of breast cancer and a mastectomy; she declined a breast prosthesis (CLM-0004, CLM-0005)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Continue tamoxifen daily with side effects she finds tolerable | 2026-09-28 | completed | Taking it daily; mild hot flashes controlled without medicine; no abnormal bleeding or clot symptoms |
| Complete the yearly surveillance mammogram of the left breast | 2026-09-28 | completed | Left mammogram one year after diagnosis: BI-RADS 1 |
| Complete germline genetic assessment, missed at diagnosis | 2026-10-19 | active | Genetic counseling completed and panel testing sent; result pending |
| Keep at least 150 minutes of activity a week and a stable weight | 2026-09-28 | completed | Walking about 200 minutes a week; weight stable at 71 to 72 kg |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Medical oncology consultation to confirm the adjuvant endocrine therapy plan, advise on hot flashes, set the surveillance plan, and advise on genetic assessment | completed | GL-NCCN-BREAST-2025, GL-ASCO-ENDO-2019 |
| Tamoxifen 20 mg daily for at least five years, with questions at every visit about hot flashes, abnormal vaginal bleeding, and leg swelling or breathlessness, and a yearly gynecologic assessment | completed | GL-ASCO-ENDO-2019, GL-CMID-2026 |
| Cancer-related history and examination every 3 to 6 months for the first 3 years and a yearly diagnostic mammogram of the left breast; no routine blood tests, tumor markers, or body imaging while she has no symptoms | completed | GL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-FU-2013 |
| Germline genetic counseling and multigene panel testing for breast cancer diagnosed at 44 | completed | GL-ASCO-SSO-GERM-2024, GL-NCCN-BREAST-2025 |
| Lymphedema risk counseling and arm checks at every visit; bone health by calcium and vitamin D from diet and weight-bearing exercise; distress, depression, and anxiety screening at intervals | completed | GL-ACS-ASCO-SURV-2016, GL-CMID-2026 |
| Written survivorship care plan, at least 150 minutes of activity a week, alcohol at or below one drink a day, and her decisions about reconstruction and a prosthesis recorded and respected | completed | GL-ACS-ASCO-SURV-2016, GL-CMID-2026 |
Planned encounters
- 2026-03-09 — Primary care survivorship visit five and a half months after right mastectomy for stage IA breast cancer, on tamoxifen (ENC-001)
- 2026-03-30 — Survivorship follow-up on the day of the medical oncology consultation (ENC-002)
- 2026-06-29 — Three-month survivorship visit on tamoxifen (ENC-003)
- 2026-09-28 — Survivorship visit one year after diagnosis, after the yearly mammogram of the left breast (ENC-004)
- 2026-10-19 — Adult preventive visit (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Care-plan review)
- Progress note 05 — Preventive Visit
- Medical Oncology referral
- Medical Oncology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Care-plan review) (XML)
- Progress note 05 — Preventive Visit (XML)
- Medical Oncology referral (XML)
- Medical Oncology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Audre Lorde | Academy of American Poets (Poets.org) | biography |
| SRC-0002 | Audre Lorde Papers: finding aid, biographical note | Spelman College Archives | primary |
| SRC-0003 | Smith TK. How Audre Lorde's Experience of Breast Cancer Fortified Her Revolutionary Politics (foreword to The Cancer Journals, Penguin Classics edition) | Literary Hub | other |
| SRC-0004 | Lorde, Audre Geraldine. The Scribner Encyclopedia of American Lives | Encyclopedia.com | biography |
| SRC-0005 | Brandman M. Audre Lorde | National Women's History Museum | biography |
| SRC-0006 | Popova M. Audre Lorde on the Transformation of Silence into Language and Action | The Marginalian | other |
| SRC-0007 | Review of A Burst of Light, by Audre Lorde | Publishers Weekly | other |
| SRC-0008 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the tamoxifen-alone decision, the surveillance plan, and the timing of genetic assessment. |
| provenance review | not_started | Recent-death rule: only what Lorde published about her own illness, as reported by the Academy of American Poets, the Spelman College Archives finding aid, a published foreword to The Cancer Journals, reference biographies, and a review of A Burst of Light. Tumor details and all treatment besides the mastectomy are synthetic. |
| safe messaging review | not_started | No behavioral-health diagnosis; her identity is described only as her own work and the cited sources describe it; her decisions about a prosthesis and later treatment are recorded as her own; death recorded without detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.